Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO

CDMO · United Kingdom

OXB (LSE:OXB) is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. Source (opens in a new tab)

Website: https://oxb.com/
Headquarters: GB
Provider types: CDMO